Robot model
Johnson & Johnson Ottava
Next-generation surgical robot in development by J&J/Ethicon.
- Manufacturer
- Johnson & Johnson
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 1
Key facts
Product
Status
Stock listing
Developing division
Company type
Revenue
Data & sources
Web sources
1
1 source backing this record.View all →
Pricing
No verified price is on record for Johnson & Johnson Ottava. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (1)
- Johnson & Johnson Ottava at New Brunswickoperational
Johnson & Johnson Ottava surgical robot in development phase.
Johnson & Johnson Ottava on the deployment map
Where Johnson & Johnson Ottava is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 11, 2026
The Next Era of Surgery | J&J MedTech
- Record createdJun 8, 2026
Added to the verified registry
Safety record
No incidents on record for Johnson & Johnson Ottava.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
- What is Johnson & Johnson Ottava?
- Next-generation surgical robot in development by J&J/Ethicon. 6-arm configuration, general surgery focus.
- How much does Johnson & Johnson Ottava cost?
- Johnson & Johnson Ottava's price is not publicly disclosed. DEPLOY has no verified price on record for Johnson & Johnson Ottava from Johnson & Johnson. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
- Is Johnson & Johnson Ottava actually deployed in the real world?
- Yes. Johnson & Johnson Ottava is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
- Who makes Johnson & Johnson Ottava?
- Johnson & Johnson Ottava is made by Johnson & Johnson, based in New Brunswick, New Jersey, USA, founded in 1886.
- Where is Johnson & Johnson Ottava deployed?
- 1 verified deployment of Johnson & Johnson Ottava is on the DEPLOY registry, including at New Brunswick.
- Can you buy Johnson & Johnson Ottava?
- Johnson & Johnson Ottava is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- What are alternatives to Johnson & Johnson Ottava?
- On the DEPLOY registry, comparable surgical robots to Johnson & Johnson Ottava include Toumai, da Vinci (and Ion), Epione, Hugo RAS.
- How does Johnson & Johnson Ottava compare to Toumai?
- Johnson & Johnson Ottava and Toumai (MicroPort MedBot · 8 deployments) are both surgical robots on the DEPLOY registry. Johnson & Johnson Ottava has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- Is Johnson & Johnson Ottava a top surgical?
- On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Johnson & Johnson Ottava ranks in roughly the top 33% of surgical models tracked by the registry.
- What is Johnson & Johnson Ottava's maturity stage?
- Johnson & Johnson Ottava is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Is Johnson & Johnson Ottava safe?
- Johnson & Johnson Ottava has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-12
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-12
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Johnson & Johnson Ottava.Recent coverage
Johnson & Johnson Ottava in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Johnson & Johnson Ottava from third-party publications. Automatically surfaced; not part of the verified registry record.
DePuy Synthes Appoints Andrew Burton as Global Head of Robotics - hrtoday.in
<a…
J&J submits FDA de novo request for Ottava robot in general surgery
Johnson and Johnson submitted a De Novo classification request to the FDA for its Ottava robotic surgical system targeting general surgery procedures in the upper abdomen. J&J…
J&J’s DePuy Synthes has a new head of robotics platforms - MassDevice
<a…
Medical robotics and AI advice from a J&J DePuy Synthes leader
“Don’t lead with AI,” he says. “AI for its own sake doesn’t mean anything. You have to start with talking to surgeons about real problems and things that would meaningfully change…
How J&J’s DePuy Synthes developed Velys software for faster hip replacements
Ahead of Johnson & Johnson MedTech‘s launch of its new Velys Hip Navigation with AI Assistance software, we interviewed DePuy Synthes President of Global Digital, Robotics Surgery…
Johnson & Johnson (JNJ): A Cheap Robotics Stock Redefining Coronary Artery Disease Treatment - Yahoo Finance
<a…
How Investors May Respond To Johnson & Johnson (JNJ) Advancing Immunology, Cardiology And Surgical Robotics Platforms - Yahoo Finance
<a…
J&J’s Ottava robot meets goals in gastric bypass study - MedTech Dive
<a…
Johnson & Johnson completes clinical study for OTTAVA robotic surgical system - The Robot Report
<a…
J&J’s Ottava surgical robot meets primary endpoints in gastric bypass study - Fierce Biotech
<a…
Johnson and Johnson Announces Pivotal Clinical Study Results for OTTAVA
Johnson and Johnson announced results from the first clinical study of the investigational OTTAVA Robotic Surgical System, demonstrating safety and efficacy for soft tissue…
Johnson & Johnson’s Ottava Robot Meets Endpoints in Pivotal Bariatric Surgery Trial - Medical Product Outsourcing
<a…
Machine-readable surfaces
- Markdown mirror: /models/ottava-surgical.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/97e94523-dc0c-45cf-be22-77e509e09e1b
- Revision history: /models/ottava-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Johnson & Johnson Ottava draws attention at the 84th percentile but verifies reality at the 23rd percentile among surgical robots. Hype Gap +61, 2nd widest among surgical robots.
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 23, 2026